Clinical Trial

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression

Study acronym: OMIMYDep
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a 12 week double blind RCT aimed to investigate the role of omega-3 fatty acids in patients with major depressive disorder
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-15.
Trial Details
NCT Number NCT07363551
Lead Sponsor China Medical University Hospital
Conditions ADHD
Enrollment 60 participants
Start Date 2021-06-09
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-26